Skip to main content Back to Top
Advertisement

9/25/2024

Pegfilgrastim-cbqv Injection

Products Affected - Description

    • Udenyca subcutaneous solution for injection, Coherus Biosciences, 6 mg, 0.6 mL prefilled single-dose auto-injector, NDC 70114-0120-01
    • Udenyca subcutaneous solution for injection, Coherus Biosciences, 6 mg/0.6 mL, prefilled syringe, NDC 70114-0101-01

Reason for the Shortage

    • Coherus has Udenyca on shortage due to third-party manufacturing constraints related to labeling and packaging of the product.

Available Products

    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Coherus has Udenyca on shortage and the company estimates supplies will be depleted by mid-October 2024. Supplies are expected to gradually become available again starting in early-November 2024.

Updated

Created September 25, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.

ADVERTISEMENT